View in EDS

Engineered T cell therapy for viral and non-viral epithelial cancers.

Saved in:
Bibliographic Details
Title: Engineered T cell therapy for viral and non-viral epithelial cancers.
Authors: Norberg SM; National Cancer Institute, Center for Immuno-Oncology, Bethesda, MD 20892, USA., Hinrichs CS; Rutgers Cancer Institute of New Jersey, Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, New Brunswick, NJ 08901, USA. Electronic address: ch977@cinj.rutgers.edu.
Source: Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 58-69. Date of Electronic Publication: 2022 Nov 17.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36400016
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineered T cell therapy for viral and non-viral epithelial cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Norberg+SM%22">Norberg SM</searchLink>; National Cancer Institute, Center for Immuno-Oncology, Bethesda, MD 20892, USA.<br /><searchLink fieldCode="AU" term="%22Hinrichs+CS%22">Hinrichs CS</searchLink>; Rutgers Cancer Institute of New Jersey, Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, New Brunswick, NJ 08901, USA. Electronic address: ch977@cinj.rutgers.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 58-69. <i>Date of Electronic Publication: </i>2022 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36400016
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ccell.2022.10.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 58
    Titles:
      – TitleFull: Engineered T cell therapy for viral and non-viral epithelial cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Norberg SM
      – PersonEntity:
          Name:
            NameFull: Hinrichs CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 01
              Text: 2023 Jan 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1878-3686
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer cell
              Type: main
ResultId 1